至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

TGF-β1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis.

Oncotarget. 2016; 
ZhouXinru,MaoYong,ZhuJianjie,MengFanyi,ChenQi,TaoLihua,LiRui,FuFengqing,LiuCuiping,HuYuanjia,WangWeipeng,ZhangHongjian,HuaDong,ChenWeichang,ZhangXueg
Products/Services Used Details Operation
DNA Sequencing The positive clones were confirmed by using PCR, restriction enzymes digestion, and DNA sequencing methods (GenScript, Nanjing, China). Get A Quote

摘要

Transforming growth factor-beta 1 (TGF-β1) suppresses T cell function, promoting tumor immune escape. Yet, whether the depression of TGF-β1 on T cell function is mediated by co-inhibitory molecules B7-H3 and B7-H4 remains largely unclear. Here, we demonstrated that TGF-β1 elevated the expression of miR-155 in colorectal cancer cells through SMAD3 and SMAD4. The upregulated miR-155 attenuated miR-143 by inhibiting its direct target, the transcription factor CEBPB. Consequently, the direct target genes of miR-143, B7-H3 and B7-H4, were augmented in the cytoplasm and membrane of tumor cells. Over-expression of B7-H3 and B7-H4 in HCT-116 cells induced T cells to secrete TGF-β1 and the immunosuppre... More

关键词

TGF-β1,co-inhibitor,colorectal cancer,microRNA,tumor eva